MLB warns players that sexual pills may contain banned PEDs

Although the company will continue to pursue „higher-risk, high reward“ drug candidates such as pegilodecakin, these will be a smaller part of the portfolio in the future, said Chief Scientific Officer Daniel Skovronsky. The teams‘ former medic, who is currently facing a fit-to-practise tribunal, paints a stark picture of the gold-medal factory across 66 pages …